Home
Centre for Cancer Biomarkers CCBIO

News archive for Centre for Cancer Biomarkers CCBIO

Helse Vest's Research Prize was this year awarded to the Gynaecologic Research Group led by CCBIO PI Helga B. Salvesen. The Innovation Award went to James Lorens at BerGenBio and UiB, also CCBIO PI.
Perhaps we should issue a time frame on the public health bureaucracy, says CCBIO Director Lars A. Akslen, when considering the time it takes new drugs to be accepted to Norway.
CCBIO applied for 4,5 million NOK over 3 years and has now been granted INTPART-funding from the Norwegian Research Council (RCN) and the Norwegian Centre for International Cooperation in Education (SIU).
At this semester’s first CCBIO Junior Scientist Symposium September 17th, there was again large interest in participating at the seminar. More than 40 registered for the whole seminar and even more participated at selected presentations.
Dr. Elisabeth Wik was awarded with 2nd best oral presentation at the European Congress of Pathology which took place in Belgrade, Serbia, September 5-9 2015.
Excited children and adults crowded the Research Fair when researchers at the Center for Cancer Biomarkers (CCBIO) performed a play about the cancer cell Greedy Frieda.
Begeistra born og vaksne stod tett i tett då forskarar ved Center for Cancer Biomarkers (CCBIO) framførte skodespelet om kreftcella Fråtse-Frida på Forskingstorget.
CCBIO’s Professor Helga Salvesen has been co-author of a study recently published in the renowned journal JAMA Oncology. The results of the study may indicate that cigarette smoke helps to activate an entire universal "cancer program" which are also present in cancer that are not usually associated with smoking, including breast and gynecological cancers.
Researchers have found five new genetic regions that make people more susceptible to malignant melanomas. CCBIO’s Lars Akslen is one of the Norwegian researchers who have been contributing to this international study.
The Marie Curie ITN Network CAFFEIN, caffein.ku.dk, arranges its first international conference in Bergen October 22nd-23rd 2015.
EU recently published an expert report on the design of indicators for promoting and monitoring Responsible Research and Innovation. Roger Strand, CCBIO's principal investigator on ethical and social aspects, was the Chairman of the expert group.
No less than 3 new CCBIO research school courses will start up this fall, and the Junior Scientist Symposia also have news to share.
Jim Lorens' research group in Tumor Cell Plasticity was June 18th 2015 awarded with the Best Research Group of the Year 2014 by the Faculty of Medicine and Dentistry, University of Bergen.
Centre Director Lars A. Akslen and Communications Adviser at CCBIO Marion Solheim were invited to the NUAS conference at Karolinska Institutet in Stockholm to share how CCBIO communicate their research activities.
Robert Kerbel, a leading expert on angiogenesis and Professor in the Department of Medical Biophysics University of Toronto, Senior Scientist at the Sunnybrook Research Institute (Toronto), and a Canada Research Chair in Tumor Biology and Angiogenesis, visited Bergen on June 11th. He gave a top lecture “Antiangiogenic Therapeutics in Oncology: Overview, Update, and Future Directions” at the joint... Read more
A new course at the Centre for Cancer Biomarkers aims to support young cancer researchers to make good decisions in matters of life and death.
Many of the world's top cancer researchers presented the latest in cancer research when the Centre for Cancer Biomarkers invited to a two-day symposium at Solstrand.
The Council of Europe, with its 47 member states, has for years been involved in international efforts for human rights and bioethics. In particular, it is known for the so-called Oviedo Convention that outlines ethical principles for biomedicine.

Pages